CLARISCAN
NDC 0407-2943, gadoterate meglumine, injection, solution, from GE Healthcare.
- Product NDC
- 0407-2943
- Status
- Listed
- Labeler
- GE Healthcare
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210016
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0407-2943 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GADOTERATE MEGLUMINE376.9 mg/mL
Pharmacologic classes
Gadolinium-based Contrast Agent [EPC]; Magnetic Resonance Contrast Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0407-2943-01 | 00407294301 | 10 VIAL, GLASS in 1 BOX (0407-2943-01) / 10 mL in 1 VIAL, GLASS |
| 0407-2943-02 | 00407294302 | 10 VIAL, GLASS in 1 BOX (0407-2943-02) / 15 mL in 1 VIAL, GLASS |
| 0407-2943-05 | 00407294305 | 10 VIAL, GLASS in 1 BOX (0407-2943-05) / 20 mL in 1 VIAL, GLASS |
| 0407-2943-06 | 00407294306 | 10 VIAL, GLASS in 1 BOX (0407-2943-06) / 5 mL in 1 VIAL, GLASS |
| 0407-2943-12 | 00407294312 | 10 SYRINGE, PLASTIC in 1 BOX (0407-2943-12) / 10 mL in 1 SYRINGE, PLASTIC |
| 0407-2943-17 | 00407294317 | 10 SYRINGE, PLASTIC in 1 BOX (0407-2943-17) / 15 mL in 1 SYRINGE, PLASTIC |
| 0407-2943-22 | 00407294322 | 10 SYRINGE, PLASTIC in 1 BOX (0407-2943-22) / 20 mL in 1 SYRINGE, PLASTIC |
| 0407-2943-70 | 00407294370 | 10 BOTTLE, PLASTIC in 1 BOX (0407-2943-70) / 100 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels?ndc=0407-2943Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0407-2943
Use it
Look up 0407-2943 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0407-2943 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0407-2943. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.